Total Payments
$2,542
2024 Payments
$783.53
Companies
32
Transactions
100
Medicare Patients
1,056
Medicare Billing
$56,707
Payment Breakdown by Category
Food & Beverage$2,442 (96.1%)
Education$99.95 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,442 | 99 | 96.1% |
| Education | $99.95 | 1 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $763.48 | 18 | $0 (2024) |
| GENZYME CORPORATION | $304.81 | 13 | $0 (2024) |
| Amgen Inc. | $202.96 | 10 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $169.96 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $99.95 | 1 | $0 (2023) |
| Novo Nordisk Inc | $91.67 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $80.52 | 3 | $0 (2024) |
| Baxter Healthcare | $79.52 | 4 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $79.33 | 3 | $0 (2024) |
| Mannkind Corporation | $55.68 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $783.53 | 37 | GENZYME CORPORATION ($159.41) |
| 2023 | $1,015 | 32 | AstraZeneca Pharmaceuticals LP ($427.14) |
| 2022 | $608.25 | 22 | AstraZeneca Pharmaceuticals LP ($302.83) |
| 2021 | $134.83 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($25.37) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes | ||||||
| 11/16/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Cardio-renal | ||||||
| 08/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Bone Health | ||||||
| 08/26/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 08/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $26.58 | General |
| Category: ACROMEGALY | ||||||
| 08/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Endocrinology | ||||||
| 07/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $45.33 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 06/21/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 06/20/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Immunology | ||||||
| 05/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Immunology | ||||||
| 05/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 19 | 19 | $3,191 | $1,524 |
| 2022 | 5 | 132 | 134 | $26,342 | $8,407 |
| 2021 | 10 | 674 | 732 | $122,034 | $38,303 |
| 2020 | 7 | 231 | 262 | $24,706 | $8,473 |
Total Patients
1,056
Total Services
1,147
Medicare Billing
$56,707
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 19 | $3,191 | $1,524 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 57 | $12,141 | $3,519 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $3,924 | $1,744 | 44.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $4,578 | $1,564 | 34.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 21 | 21 | $2,163 | $853.23 | 39.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 17 | $3,536 | $727.02 | 20.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 174 | 203 | $40,209 | $12,099 | 30.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 133 | 133 | $28,682 | $9,481 | 33.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 166 | 182 | $27,482 | $9,338 | 34.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 41 | 41 | $8,733 | $2,302 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 28 | $4,938 | $1,925 | 39.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 40 | 42 | $8,736 | $1,816 | 20.8% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 18 | 19 | $1,026 | $859.37 | 83.8% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 16 | 16 | $816.00 | $264.48 | 32.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 46 | 52 | $676.00 | $117.00 | 17.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 16 | $736.00 | $100.90 | 13.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 125 | 137 | $15,344 | $4,962 | 32.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 21 | 21 | $3,465 | $1,049 | 30.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 15 | $2,468 | $978.79 | 39.7% |
| 87426 | Coronavirus ag ia | Office | 2020 | 19 | 19 | $1,026 | $859.37 | 83.8% |
| 87804 | Detection test for influenza virus | Office | 2020 | 14 | 28 | $1,428 | $456.80 | 32.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 13 | 13 | $598.00 | $102.52 | 17.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 24 | 29 | $377.00 | $64.75 | 17.2% |
About Ashley Codding, PA-C, RD/LD
Ashley Codding, PA-C, RD/LD is a Dietitian, Registered healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1124385885.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Codding, PA-C, RD/LD has received a total of $2,542 in payments from pharmaceutical and medical device companies, with $783.53 received in 2024. These payments were reported across 100 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,442).
As a Medicare-enrolled provider, Codding has provided services to 1,056 Medicare beneficiaries, totaling 1,147 services with total Medicare billing of $56,707. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Dietitian, Registered
- Other Specialties Registered|Physician Assistant
- Location Oklahoma City, OK
- Active Since 04/19/2012
- Last Updated 02/03/2016
- Taxonomy Code 133V00000X
- Entity Type Individual
- NPI Number 1124385885
Products in Payments
- TEZSPIRE (Biological) $624.70
- DUPIXENT (Biological) $485.28
- FASENRA (Biological) $326.56
- GVOKE HYPOPEN (Drug) $122.07
- UNITHROID (Drug) $79.33
- Ozempic (Drug) $71.36
- ZENPEP (Drug) $69.84
- Hillrom - Vest System Model 105 Home Care (Device) $59.17
- AFREZZA (Drug) $55.68
- SMARTVEST (Device) $46.78
- CeQur Simplicity (Device) $45.33
- FREESTYLE LIBRE 3 (Device) $43.63
- ALKINDI (Drug) $37.54
- NUCALA (Biological) $31.41
- MYCAPSSA (Drug) $26.58
- JARDIANCE (Drug) $25.88
- GVOKE PFS (Drug) $24.83
- SYNAGIS (Drug) $24.45
- Korlym (Drug) $24.19
- Crysvita (Drug) $23.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dietitian, Registered Doctors in Oklahoma City
Erin Krueger, Pa-C, PA-C
Dietitian, Registered — Payments: $1,365
Dietitian, Registered $1,365
Marilyn Dougherty, R.d, R.D
Dietitian, Registered
Dietitian, Registered
Dr. Patti Landers, Ph.d., R.d./L.d, PH.D., R.D./L.D
Dietitian, Registered
Dietitian, Registered
Mrs. Jani Van Grevenhof, Ms, Rd/Ld, Cde, MS, RD/LD, CDE
Dietitian, Registered
Dietitian, Registered
Barbara Payne, Rdld, RDLD
Dietitian, Registered
Dietitian, Registered
Michelle Shultz, R.d., L.d, R.D., L.D
Dietitian, Registered
Dietitian, Registered